0
Obstructive Lung Diseases |

Impact of Chronic Obstructive Pulmonary Disease on Echocardiographic Parameters in Patients Hospitalized With Acute Decompensated Heart Failure

Jignesh Patel*, MD; Hal Skopicki, MD; Puja Parikh, MD; Abhijeet Singh, MD; Smadar Kort, MD
Author and Funding Information

Stony Brook University Medical Center, Stony Brook, NY


Chest. 2012;142(4_MeetingAbstracts):668A. doi:10.1378/chest.1390560
Text Size: A A A
Published online

Abstract

SESSION TYPE: COPD Posters II

PRESENTED ON: Wednesday, October 24, 2012 at 01:30 PM - 02:30 PM

PURPOSE: Chronic obstructive pulmonary disease (COPD) may complicate the clinical prognosis of the heart failure patient. We sought to evaluate the impact of COPD on echocardiographic characteristics in patients admitted with acutely decompensated heart failure (ADHF).

METHODS: Echocardiograms were performed upon hospital admission for 181 patients admitted with a primary diagnosis of ADHF to a tertiary teaching hospital from January 2007 to June 2008. Echocardiographic parameters examined included left ventricular ejection fraction (LVEF), LV cavity size, left atrial (LA) size, interventricular septum (IVS), LV posterior width (LVPW), presence and severity of mitral (MR) and tricuspid regurgitation (TR), transmitral early (E) and late (A) filling velocities, deceleration times, mitral annular early diastolic velocities (E’), right ventricular (RV) and right atrial (RA) cavity sizes, and RV systolic pressure (RVSP).

RESULTS: Among 181 patients, 40 (22.1%) patients reported a history of COPD while 141 (77.9%) reported no such history. No significant difference was noted with respect to age (74 vs 71 years, p=0.250) or gender (males 48% vs 58%, p=0.231) between COPD and non-COPD patients; however, a trend toward higher rates of diabetes (58% vs 40%, p=0.055) was noted in the COPD group. COPD patients had significantly higher LVEF (45% vs 38%, p=0.034) and a trend towards lower rates of significant MR (15% vs 30%, p=0.068). No differences were noted in LV and LA cavity size, IVS, LVPW, transmitral E and A velocities, mitral deceleration times, RV enlargement, RVSP, RA size, and significant TR. COPD patients, however, were found to have higher average E’ velocity (11.8cm/s vs 7.7cm/s, p=0.029), but no difference in average E/E’ ratios (14.7 vs 15.2, p=0.826). Patients with COPD also had higher serum bicarbonate and troponin-I levels but no difference in admission B-type natriuretic peptide (BNP) levels. COPD patients demonstrated a trend towards higher rates of all-cause mortality at six months (23% vs 11%, p=0.071).

CONCLUSIONS: Co-existing COPD in patients admitted with ADHF is associated with worse prognosis, despite better LV systolic function.

CLINICAL IMPLICATIONS: Patients with heart failure and comorbid COPD may require more frequent followup and closer monitoring to reduce the risk of adverse cardiac events.

DISCLOSURE: The following authors have nothing to disclose: Jignesh Patel, Hal Skopicki, Puja Parikh, Abhijeet Singh, Smadar Kort

No Product/Research Disclosure Information

Stony Brook University Medical Center, Stony Brook, NY

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543